MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijpharm.2025.125634

Медицинская библиотека · International journal of pharmaceutics · 2025

Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia.

Bourguignon Tom, Godinez-Leon Jesus Alfredo, Pochet Amine, Shamsuddin Tahmida, Sencio Valentin, Chatagnon Jonathan, Grandé Axelle, Fine Joan, Heumel Séverine, Robil Cyril, Delval Lou, Piveteau Catherine, Belouzard Sandrine, Brodin Priscille, Trottein François, Machelart Arnaud, Gref Ruxandra

СтатьяПеревод пока не подготовлен

Аннотация

Despite the progress made through vaccination campaigns and the use of antivirals, the need for more effective therapeutics to combat respiratory viral infections remains critical. A recent screening of over 2000 repurposed molecules has identified the antibiotic clofoctol (CFT) as a promising candidate for treating COVID-19. However, administering CFT systemically poses challenges due to its low solubility and potential toxicity. In this study, we engineered poly(lactic-co-glycolic) acid (PLGA)-based nanoparticles (NPs) designed to encapsulate high payloads of CFT, allowing for a controlled drug release in the pulmonary environment. Pharmacokinetic studies demonstrated high CFT bioavailability 8 h after intranasal (i.n.) administration. In preclinical models (mouse and hamster) of COVID-19, i.n. administration of CFT-loaded NPs significantly reduced pulmonary viral loads. Remarkably, vectorized CFT also decreased inflammation and improved pathological scores in the lungs. These results pave the way for a groundbreaking CFT formulation designed to tackle the challenges posed by acute respiratory infections. This study marks the first demonstration of a stable, effective and well-tolerated CFT formulation for the treatment of lung diseases.

Для цитирования: Bourguignon Tom, Godinez-Leon Jesus Alfredo, Pochet Amine, Shamsuddin Tahmida, Sencio Valentin, Chatagnon Jonathan, Grandé Axelle, Fine Joan, Heumel Séverine, Robil Cyril, Delval Lou, Piveteau Catherine, Belouzard Sandrine, Brodin Priscille, Trottein François, Machelart Arnaud, Gref Ruxandra. Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia.. International journal of pharmaceutics. 2025. DOI: 10.1016/j.ijpharm.2025.125634.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.